{"id":2750,"date":"2021-11-22T14:00:00","date_gmt":"2021-11-22T14:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/"},"modified":"2021-11-22T14:00:00","modified_gmt":"2021-11-22T14:00:00","slug":"xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/","title":{"rendered":"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA"},"content":{"rendered":"
\n

F\u00f6r att forts\u00e4tta optimera processen f\u00f6r kommersialisering av XVIVOs unika teknologier har Jaya Tiwari utsetts till Vice President Clinical and Regulatory Affairs f\u00f6r den amerikanska marknaden, som ocks\u00e5 \u00e4r den viktigaste marknaden f\u00f6r XVIVO. Den nya positionen kommer att ing\u00e5 i XVIVOs ledningsgrupp. Jaya har stor erfarenhet av ett n\u00e4ra samarbete med FDA som resulterat i effektiva processer f\u00f6r godk\u00e4nnanden f\u00f6r kliniska pr\u00f6vningar och registrering av nya produkter.<\/strong><\/p>\n<\/div>\n

\n

Jaya har varit anst\u00e4lld p\u00e5 XVIVO i sex \u00e5r. Ut\u00f6ver sin erfarenhet av FDA-processer har hon stor kunskap inom prekliniska och kliniska studier, och vet hur man effektivt samarbetar med olika institutioner. Dessutom har hon goda relationer med m\u00e5nga viktiga opinionsbildare inom organtransplantation i USA.
\u00a0
Hon har sin akademiska examen i Neural Science fr\u00e5n New York University och har en PICTOR (Pulmonary & Intensive Care Translational Outcomes Research) Scholar fr\u00e5n Columbia University, USA. Innan anst\u00e4llningen hos XVIVO ledde Jaya forskningsprogram vid University of Pennsylvania och Columbia University, d\u00e4r hon var djupt involverad i studier inom organperfusion, transplantation och onkologi. Jaya har \u00e4ven publicerat artiklar i vetenskapliga tidskrifter.
\u00a0
"Att n\u00e5 framg\u00e5ng i USA \u00e4r v\u00e4ldigt mycket beroende av att ha effektiva och tydliga strategier f\u00f6r de kliniska och regulatoriska omr\u00e5dena. Nu n\u00e4r Jaya blir del av v\u00e5r ledningsgrupp, d\u00e4r hon kommer att rapportera till v\u00e5r CMO Andreas Wallinder, s\u00e5 k\u00e4nner jag mig s\u00e4ker p\u00e5 att vi har r\u00e4tt kompetens och erfarenhet p\u00e5 plats f\u00f6r att leverera p\u00e5 v\u00e5r strategiska plan f\u00f6r USA. Jag \u00e4r mycket stolt och glad \u00f6ver att Jaya har tackat ja d\u00e5 rollen kommer att vara central f\u00f6r XVIVOs framg\u00e5ng\u201d, s\u00e4ger Dag Andersson, VD f\u00f6r XVIVO.<\/p>\n<\/div>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n\n

Dag Andersson, VD, +46 31-788 21 50,\u00a0dag.andersson@xvivogroup.com
Kristoffer\u00a0Nordstr\u00f6m,\u00a0CFO, +46 73-519 21 64,\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n

\n

Om oss<\/strong><\/p>\n\n

XVIVO grundades 1998 och \u00e4r ett medicintekniskt f\u00f6retag dedikerat till att f\u00f6rl\u00e4nga livet f\u00f6r donerade organ s\u00e5 att transplantationsteam runt om i v\u00e4rlden kan r\u00e4dda fler liv. V\u00e5ra l\u00f6sningar g\u00f6r det m\u00f6jligt f\u00f6r ledande kliniker och forskare att t\u00e4nja p\u00e5 gr\u00e4nserna f\u00f6r transplantationsmedicin.\u00a0XVIVO har sitt huvudkontor i G\u00f6teborg och har kontor och forskningsanl\u00e4ggningar p\u00e5 tv\u00e5 kontinenter. Bolaget \u00e4r noterat p\u00e5 Nasdaq Stockholm\u00a0och handlas under symbolen XVIVO. Mer information finns att l\u00e4sa p\u00e5 hemsidan www.xvivogroup.com\/us<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n\n

XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

F\u00f6r att forts\u00e4tta optimera processen f\u00f6r kommersialisering av XVIVOs unika teknologier har Jaya Tiwari utsetts till Vice President Clinical and…<\/p>\n","protected":false},"template":"","class_list":["post-2750","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-staff"],"acf":[],"yoast_head":"\nXVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO\" \/>\n<meta property=\"og:description\" content=\"F\u00f6r att forts\u00e4tta optimera processen f\u00f6r kommersialisering av XVIVOs unika teknologier har Jaya Tiwari utsetts till Vice President Clinical and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\\\/\",\"name\":\"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2021-11-22T14:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO","og_description":"F\u00f6r att forts\u00e4tta optimera processen f\u00f6r kommersialisering av XVIVOs unika teknologier har Jaya Tiwari utsetts till Vice President Clinical and...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/","name":"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2021-11-22T14:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-utokar-sin-ledningsgrupp-genom-att-utse-jaya-tiwari-till-vice-president-clinical-and-regulatory-affairs-for-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO ut\u00f6kar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs f\u00f6r USA"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}